Veru, Inc. (VERU)
2.30
-0.14
(-5.74%)
USD |
NASDAQ |
Oct 16, 16:00
2.29
-0.01
(-0.43%)
After-Hours: 20:00
Veru Free Cash Flow : -26.04M for June 30, 2026
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| June 30, 2026 | -26.04M |
| March 31, 2026 | -26.06M |
| December 31, 2025 | -24.88M |
| September 30, 2025 | -30.04M |
| June 30, 2025 | -28.98M |
| March 31, 2025 | -29.20M |
| December 31, 2024 | -27.15M |
| September 30, 2024 | -21.84M |
| June 30, 2024 | -27.12M |
| March 31, 2024 | -39.87M |
| December 31, 2023 | -59.88M |
| September 30, 2023 | -88.68M |
| June 30, 2023 | -100.00M |
| March 31, 2023 | -95.66M |
| December 31, 2022 | -74.10M |
| September 30, 2022 | -48.24M |
| June 30, 2022 | -28.24M |
| March 31, 2022 | -27.10M |
| December 31, 2021 | -25.56M |
| September 30, 2021 | -15.95M |
| June 30, 2021 | -15.29M |
| March 31, 2021 | 1.004M |
| December 31, 2020 | 1.148M |
| September 30, 2020 | -2.036M |
| June 30, 2020 | -2.651M |
| Date | Value |
|---|---|
| March 31, 2020 | -6.573M |
| December 31, 2019 | -6.620M |
| September 30, 2019 | -5.594M |
| June 30, 2019 | -7.423M |
| March 31, 2019 | -11.30M |
| December 31, 2018 | -13.40M |
| September 30, 2018 | -11.60M |
| June 30, 2018 | -8.216M |
| March 31, 2018 | -2.312M |
| December 31, 2017 | 0.0438M |
| September 30, 2017 | 0.8494M |
| June 30, 2017 | -0.5396M |
| March 31, 2017 | -1.550M |
| December 31, 2016 | -0.1863M |
| September 30, 2016 | -1.721M |
| June 30, 2016 | 0.5859M |
| March 31, 2016 | -0.1422M |
| December 31, 2015 | -0.8959M |
| September 30, 2015 | -1.684M |
| June 30, 2015 | -0.9913M |
| March 31, 2015 | -0.3701M |
| December 31, 2014 | 1.246M |
| September 30, 2014 | 3.568M |
| June 30, 2014 | 0.4179M |
| March 31, 2014 | 7.841M |
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| ANI Pharmaceuticals, Inc. | 167.52M |
| Corcept Therapeutics, Inc. | 106.92M |
| Johnson & Johnson | 22.61B |
| Eli Lilly & Co. | 13.56B |
| Lexicon Pharmaceuticals, Inc. | -64.99M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -5.467M |
| Cash from Investing (Quarterly) | 1.802M |
| Cash from Financing (Quarterly) | -0.0519M |
| Free Cash Flow Per Share (Quarterly) | -0.2372 |
| Free Cash Flow to Equity (Quarterly) | -5.317M |
| Free Cash Flow to Firm (Quarterly) | -5.467M |
| Free Cash Flow Yield | -55.87% |